NURIX THERAPEUTICS IN
22.00
08-October-24 15:59:59
15 minutes delayed
Stocks
+0.46
+2.14%
Today's range
21.30 - 22.72
ISIN
N/A
Source
NASDAQ
-
20 Mar 2024 09:40:00 By Nasdaq GlobeNewswire
-
Nurix Therapeutics Announces U.S. FDA Lifts Partial Clinical Hold on NX-2127 Phase 1 Trial
11 Mar 2024 07:00:00 By Nasdaq GlobeNewswire
-
Nurix Therapeutics to Participate in Upcoming Investor Conferences
06 Mar 2024 16:00:00 By Nasdaq GlobeNewswire
-
05 Mar 2024 16:30:00 By Nasdaq GlobeNewswire
-
15 Feb 2024 16:00:00 By Nasdaq GlobeNewswire
-
01 Feb 2024 16:01:00 By Nasdaq GlobeNewswire
-
16 Jan 2024 16:01:00 By Nasdaq GlobeNewswire
-
08 Jan 2024 07:00:00 By Nasdaq GlobeNewswire
-
Nurix Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
02 Jan 2024 16:01:00 By Nasdaq GlobeNewswire
-
Nurix Therapeutics to Participate in Upcoming Investor Conferences
07 Nov 2023 16:01:00 By Nasdaq GlobeNewswire
-
02 Nov 2023 09:00:01 By Nasdaq GlobeNewswire
-
Nurix Therapeutics Announces Partial Clinical Hold For NX-2127 Phase 1 Trial
01 Nov 2023 16:01:00 By Nasdaq GlobeNewswire
-
12 Oct 2023 16:01:00 By Nasdaq GlobeNewswire
-
Nurix Therapeutics to Participate in Upcoming Investor Conferences
31 Aug 2023 16:01:00 By Nasdaq GlobeNewswire
-
13 Jul 2023 16:01:00 By Nasdaq GlobeNewswire